Novartis Investigative Site

Rugby CV22 5PX

0 studies enrolling now · 2 studies all time

What they study most

Age-related Macular Degeneration, Cardiovascular Disease, Type 2 Diabetes Mellitus

Studies at this site

• Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early